Expertise in

conditions

Dr. Stephanie A. Berg

Oncology

Dana-Farber Cancer Institute

450 Brookline Ave,

Boston, MA

Clinical Trials:Currently Recruiting for 3 Trials

Accepting New Patients

Offers Telehealth

Expertise in

conditions

Dana-Farber Cancer Institute

450 Brookline Ave,

Boston, MA

Overview

Stephanie Berg is an Oncologist practicing medicine in Boston, Massachusetts.

Dr. Berg is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Burkitt Lymphoma, Urothelial Cancer, Renal Cell Carcinoma (RCC), Bone Marrow Aspiration, and Nephrectomy.

She is actively involved in clinical research, co-authoring 54 peer reviewed articles and participating in 8 clinical trials. Dr. Berg is currently accepting new patients.

Specialties

Oncology

Licenses

Internal Medicine in MA

Hospital Affiliations

Loyola University Medical Center

Brigham And Women Faulkner Hospital

Cooley Dickinson Hospital Inc,the

Brigham And Women's Hospital

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance

Find your insuranceClose

Accepted insurance plans:

Aetna

Anthem BCBS

Blue Cross Blue Shield

CareFirst

Cigna

Commonwealth Care Alliance

MANAGED MEDICAID PLAN
MEDICARE MAPD
MEDICARE PDP
MEDICARE SNP
MEDICARE-MEDICAID PLAN

Health Care Services Corporation

HMO
INSURANCE PLAN
MANAGED MEDICAID PLAN
MEDICARE MAPD
MEDICARE PDP
MEDICARE SNP
OTHER COMMERCIAL
OTHER MEDICARE
OTHER MEDICARE PART D
PPO

Humana

HMO
INDEMNITY
POS
PPO

Managed Medicaid

OTHER MANAGED MEDICAID

Mass General Brigham Health Plan

HMO
INSURANCE PLAN
MANAGED MEDICAID PLAN
PPO

Medicaid

OTHER MEDICAID
STATE MEDICAID

Meridian Choice

HMO
INSURANCE PLAN
MANAGED MEDICAID PLAN
MEDICARE MAPD
MEDICARE SNP
MEDICARE-MEDICAID PLAN
OTHER COMMERCIAL
OTHER MEDICARE
OTHER MEDICARE PART D

Tufts

UnitedHealthcare

Walgreens

MEDICARE DISCOUNT CARD
MEDICARE PDP
OTHER MEDICARE

Wellcare

EPO
HMO
INSURANCE PLAN
MANAGED MEDICAID PLAN
MEDICARE MAPD
MEDICARE PDP
MEDICARE SNP
MEDICARE-MEDICAID PLAN
OTHER MEDICARE
OTHER MEDICARE PART D

View 11 Less Insurance Carriers -

Locations

Dana-Farber Cancer Institute
450 Brookline Ave, Boston, MA 02215

Call: 877-442-3324

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Phase II Study of Ipilimumab, Cabozantinib, and Nivolumab in Rare Genitourinary Cancers (ICONIC)

Enrollment Status: Recruiting

Publish Date: September 08, 2026

Intervention Type: Procedure, Biological, Drug

Study Drugs: Cabozantinib, Ipilimumab, Nivolumab

Study Phase: Phase 2

Establishment of a National Biorepository to Advance Studies of Immune-Related Adverse Events

Enrollment Status: Recruiting

Publish Date: September 02, 2026

Intervention Type: Procedure, Other

Phase III Trial of Immunotherapy-Based Combination Therapy With or Without Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma (PROBE Trial)

Enrollment Status: Recruiting

Publish Date: September 09, 2025

Intervention Type: Drug, Procedure

Study Phase: Phase 3

PD-Inhibitor (Nivolumab) and Ipilimumab Followed by Nivolumab Vs. VEGF TKI Cabozantinib With Nivolumab: A Phase III Trial in Metastatic Untreated REnal Cell CancEr [PDIGREE]